Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SERPINC1 known ✓ | P01008 | 1/20 | 0.53 |
| ▸ | F10 known ✓ | P00742 | 4/20 | 0.47 |
| ▸ | FGF1 known ✓ | P05230 | 1/20 | 0.45 |
| ▸ | HPSE | Q9Y251 | 10/20 | 0.57 |
| ▸ | F2 | P00734 | 1/20 | 0.53 |
| ▸ | BMP2 | P12643 | 2/20 | 0.50 |
| ▸ | VEGFA | P15692 | 2/20 | 0.50 |
| ▸ | CXCL12 | P48061 | 2/20 | 0.50 |
| ▸ | SHH | Q15465 | 2/20 | 0.50 |
| ▸ | PF4 | P02776 | 2/20 | 0.49 |
| ▸ | IFNG | P01579 | 1/20 | 0.49 |
| ▸ | CCL2 | P13500 | 1/20 | 0.49 |
| ▸ | SELP | P16109 | 1/20 | 0.49 |
| ▸ | BMP6 | P22004 | 1/20 | 0.49 |
| ▸ | CCL11 | P51671 | 1/20 | 0.49 |
| ▸ | WNT3A | P56704 | 1/20 | 0.49 |
| ▸ | SELPLG | Q14242 | 1/20 | 0.49 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.45 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.45 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29485090 | 0.83 | FGF1 (0.49) | HPSEF2SERPINC1BMP2VEGFA | |
| SCHEMBL29399259 | 0.82 | LGALS3 (0.63) | HPSEVEGFAFGF1LGALS3LGALS8 | |
| SCHEMBL29540534 | 0.82 | HPSE (0.45) | HPSEF2SERPINC1BMP2VEGFA | |
| SCHEMBL29406391 | 0.82 | HPSE (0.45) | HPSEF2SERPINC1BMP2VEGFA | |
| SCHEMBL30110520 | 0.81 | LGALS3 (0.60) | HPSELGALS3LGALS8LGALS4 | |
| SCHEMBL29370786 | 0.81 | LGALS3 (0.60) | HPSELGALS3LGALS8LGALS4 | |
| SCHEMBL17148015 | 0.81 | LGALS3 (0.60) | HPSELGALS3LGALS8LGALS4 | |
| SCHEMBL17148009 | 0.81 | LGALS3 (0.60) | HPSELGALS3LGALS8LGALS4 | |
| SCHEMBL30089435 | 0.81 | BDNF (0.53) | HPSEF2SERPINC1BMP2VEGFA | |
| SCHEMBL30089363 | 0.81 | F10 (0.48) | HPSEF2SERPINC1BMP2VEGFA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12551714-B2 | Magnetic stimulation of the spinal cord to restore locomotor function and/or control of bladder and bowel | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-02-17 | — | — | US | claimed |
| US-12478777-B2 | Non-invasive spinal cord stimulation for nerve root palsy, cauda equina syndrome, and restoration of upper extremity function | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-11-25 | — | — | US | claimed |
| US-12434068-B2 | Accessing spinal networks to address sexual dysfunction | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-10-07 | — | — | US | claimed |
| EP-4299106-B1 | ACCESSING SPINAL NETWORK TO ENABLE RESPIRATORY FUNCTION | UNIV CALIFORNIA (US) | 2025-09-03 | — | — | EP | claimed |
| US-20250235694-A1 | TRANSCUTANEOUS ELECTRICAL SPINAL CORD NEUROMODULATOR AND USES THEREOF | UNIVERSITY OF SOUTHERN CALIFORNIA | 2025-07-24 | — | — | US | claimed |
| WO-2025102600-A1 | NOVEL HETEROCYCLIC COMPOUND | 首药控股(北京)股份有限公司 | 2025-05-22 | — | — | WO | claimed |
| EP-4464854-A1 | PREFABRICATED STRUCTURAL ELEMENT FOR THE CONSTRUCTION A SLAB OF A BUILDING | Besd Technology S.r.l. (IT) | 2024-11-20 | — | — | EP | claimed |
| EP-4464314-A2 | TRANSCUTANEOUS ELECTRICAL SPINAL CORD NEUROMODULATOR AND USES THEREOF | The Regents of the University of California (US) | 2024-11-20 | — | — | EP | claimed |
| EP-4299106-A2 | ACCESSING SPINAL NETWORK TO ENABLE RESPIRATORY FUNCTION | The Regents of The University of California (US) | 2024-01-03 | — | — | EP | claimed |
| US-20220233848-A1 | TRANSCUTANEOUS ELECTRICAL SPINAL CORD NEUROMODULATOR AND USES THEREOF | SCUOLA INTERNAZIONALE SUPERIORE DI STUDI AVANZATI - SISSA (IT) | 2022-07-28 | — | — | US | claimed |
| CN-114739954-A | System and method for simultaneously measuring thermal expansion coefficient and temperature refractive index coefficient of object | 北京交通大学 | 2022-07-12 | — | — | CN | claimed |
| CN-114645871-A | Axial-flow impeller, axial-flow fan with same and air conditioner | 青岛海尔空调电子有限公司 | 2022-06-21 | — | — | CN | claimed |
| US-20220161042-A1 | MAGNETIC STIMULATION OF THE SPINAL CORD TO RESTORE CONTROL OF BLADDER AND/OR BOWEL | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-05-26 | — | — | US | claimed |
| EP-3972683-A1 | TRANSCUTANEOUS ELECTRICAL SPINAL CORD NEUROMODULATOR AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-03-30 | — | — | EP | claimed |
| US-12623070-B2 | Transcutaneous electrical spinal cord neuromodulator and uses thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-05-12 | — | — | US | disclosed |
| US-20260129835-A1 | SEMICONDUCTOR DEDVICE AND METHOD FOR FABRICATING THE SAME | SK HYNIX INC (KR) | 2026-05-07 | — | — | US | disclosed |
| US-20260099449-A1 | PORTABLE ELECTRONIC DEVICE COMPRISING A MICROCONTROLLER, A SECURE ELEMENT AND A PERIPHERAL COMPONENT CONTROLLED BY THE SECURE ELEMENT | LEDGER (FR) | 2026-04-09 | — | — | US | disclosed |
| US-11264584-B2 | Display device and method for manufacturing same | SHARP KABUSHIKI KAISHA (JP) | 2022-03-01 | — | — | US | disclosed |
| US-11252833-B2 | Foldable electronic device and hinge module thereof | SYNCMOLD ENTERPRISE CORP. (TW) | 2022-02-15 | — | — | US | disclosed |
| CN-114029915-A | Marking device and marking method for cotton supporting frame of cotton picking and packaging integrated machine | 中国铁建重工集团股份有限公司 | 2022-02-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260099449-A1 | PORTABLE ELECTRONIC DEVICE COMPRISING A MICROCONTROLLER, A SECURE ELEMENT AND A PERIPHERAL COMPONENT CONTROLLED BY THE SECURE ELEMENT | PTPN13, DUSP23, PTPRE | SERPINC1 1036/4885F10 715/4885FGF1 1044/4885 |
| US-12623070-B2 | Transcutaneous electrical spinal cord neuromodulator and uses thereof | NCS1, CHRNA10, CHRNA4 | SERPINC1 2086/4885F10 2751/4885FGF1 2163/4885 |
| US-12551714-B2 | Magnetic stimulation of the spinal cord to restore locomotor function and/or control of bladder and bowel | SMN1; SMN2, MUSK, CHRNB4 | SERPINC1 3596/4885F10 3450/4885FGF1 1230/4885 |
| US-20260129835-A1 | SEMICONDUCTOR DEDVICE AND METHOD FOR FABRICATING THE SAME | CD47, ICOS, CD274 | SERPINC1 4259/4885F10 4109/4885FGF1 959/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.